Skip to content

Clinical Study of TEAS Combined with Lidocaine Nebulized Anesthesia in Bronchoscopy

Clinical Study of TEAS Combined with Lidocaine Nebulized Anesthesia in Bronchoscopy

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085718
Enrollment
Unknown
Registered
2024-06-17
Start date
2024-06-30
Completion date
Unknown
Last updated
2024-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None

Interventions

Lidocaine-only nebulization group:Nebulized lidocaine inhalation before bronchoscopy
TEAS group combined with lidocaine nebulization group:Bronchoscopy was performed before TEAS treatment and lidocaine nebulized anesthesia

Sponsors

Ethics Committee of Affiliated Hospital of Nanjing University of Traditional Chinese Medicine (Traditional Chinese Medicine Hospital of Jiangsu Province)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Meet the indications and contraindication criteria for bronchoscopy in the "Guidelines for the Application of Diagnostic Flexible Bronchoscopy in Adults (2019 Edition)"; 2. Clear consciousness, normal cognitive function, able to cooperate with the examination; 3. Age 25-80 years old; 4. Willing to accept TEAS treatment and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with severe hypoxemia, arrhythmia, recent myocardial infarction, unstable angina, aortic dissection, uncorrectable bleeding, severe pulmonary hypertension, superior vena cava syndrome, laryngeal edema and other diseases; 2. Those who are mentally ill and cannot cooperate with the examination; 3. Those who are intolerant to lidocaine hydrochloride injection; 4. Those with poor control of underlying diseases (such as patients with high blood pressure who have large fluctuations in blood pressure recently).

Design outcomes

Primary

MeasureTime frame
Score of the effect of the insertion;Total time to insert tracheoscope;Intraoperative anesthetic supplemental dose;

Secondary

MeasureTime frame
Preoperative anxiety score;blood pressure;heart rate;pulse oxygen saturation;respiratory rate;postoperative VAS scores;Number of intraoperative adverse reactions;Repeat surgery willingness questionnaire;Discomfort score 2 hours after surgery;

Countries

China

Contacts

Public ContactWei Yu

Jiangsu Provincial Hospital of Traditional Chinese Medicine

jsszyyhxk@163.com+86 139 5194 2201

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026